You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Johnson & Johnson is a multinational healthcare conglomerate that develops, manufactures, and markets a broad range of pharmaceuticals, medical devices, and consumer health products. Its business model combines research‑driven drug development, innovative surgical and diagnostic equipment, and well‑known consumer brands such as Tylenol, Band‑Aid and Neutrogena. The company operates across the health‑care sector, spanning pharmaceuticals, medical devices, and consumer health segments. Johnson & Johnson is one of the world’s largest and most diversified health‑care firms, with a strong global presence, extensive R&D capabilities, and a reputation for stable, long‑term product pipelines.
Quarterly Earnings
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q2 FY26 | Jul 15, 2026 | — |
| Q1 FY26 | Apr 14, 2026 | $2.14 |
| Q4 FY25 | Jan 21, 2026 | $2.46 |
| Q3 FY25 | Oct 14, 2025 | $2.80 |
| Q2 FY25 | Jul 16, 2025 | $2.77 |
Stay ahead of JNJ earnings
Get reminders ahead of JNJ's next earnings report, so you always know when results are coming.